Literature DB >> 7629226

Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.

N Horiba1, T Suda, M Aiba, M Naruse, K Nomura, M Imamura, H Demura.   

Abstract

We present two patients with Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia who showed marked plasma cortisol response to lysine-8-vasopressin (LVP) injection (from 930 and 731 pmol/L to 2177 and 1920 pmol/L, respectively), while plasma ACTH levels remained undetectable. The ACTH independence of cortisol secretion in the two patients was determined from the following endocrinological findings. Plasma cortisol levels were not increased by corticotropin-releasing hormone injections and were not suppressed by high dose (16 mg) dexamethasone administrations. The plasma ACTH levels, measured by two independent sensitive immunoassays, were persistently undetectable even after corticotropin-releasing hormone injection, metyrapone administration, and bilateral adrenalectomy. The particular pathological finding of the two cases, atrophic lesions in nonnodular parts of the adrenal cortexes, also indicated ACTH independence of the macronodular hyperplasia. In vitro examination revealed a direct effect of LVP on cortisol secretion from the adrenal cells of the macronodules. We also examined seven patients with Cushing's syndrome caused by adrenal adenoma and found a statistically significant plasma cortisol response to LVP injection. The direct effect of LVP was also demonstrated in cultured adenoma cells. In conclusion, we discovered a direct adrenal effect of LVP on cortisol secretion in patients with ACTH-independent macronodular hyperplasia and, to a lesser extent, in patients with cortisol-producing adrenal adenoma. The cortisol response to LVP may serve to facilitate their diagnosis and choice of therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629226     DOI: 10.1210/jcem.80.8.7629226

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland.

Authors:  Nobuhiro Miyamura; Tetsuya Taguchi; Yusuke Murata; Kayo Taketa; Shinsuke Iwashita; Kazuya Matsumoto; Takeshi Nishikawa; Tetsushi Toyonaga; Michiharu Sakakida; Eiichi Araki
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

Review 2.  Aberrant expression of hormone receptors in adrenal Cushing's syndrome.

Authors:  Stavroula Christopoulos; Isabelle Bourdeau; André Lacroix
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

3.  ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences.

Authors:  Stéphanie Espiard; Ludivine Drougat; Rossella Libé; Guillaume Assié; Karine Perlemoine; Laurence Guignat; Gaelle Barrande; Françoise Brucker-Davis; Françoise Doullay; Stephanie Lopez; Emmanuel Sonnet; Florence Torremocha; Denis Pinsard; Nathalie Chabbert-Buffet; Marie-Laure Raffin-Sanson; Lionel Groussin; Françoise Borson-Chazot; Joël Coste; Xavier Bertagna; Constantine A Stratakis; Felix Beuschlein; Bruno Ragazzon; Jérôme Bertherat
Journal:  J Clin Endocrinol Metab       Date:  2015-04-08       Impact factor: 5.958

4.  Successful Treatment of Estrogen Excess in Primary Bilateral Macronodular Adrenocortical Hyperplasia with Leuprolide Acetate.

Authors:  Fady Hannah-Shmouni; Andreas G Moraitis; Vladimir Valera Romero; Fabio R Faucz; Spyridon A Mastroyannis; Annabel Berthon; Richard A Failor; Maria Merino; Andrew P Demidowich; Constantine A Stratakis
Journal:  Horm Metab Res       Date:  2017-11-28       Impact factor: 2.936

5.  Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II.

Authors:  Y Nakamura; Y Son; Y Kohno; D Shimono; N Kuwamura; H Koshiyama; H Sasano; T Matsuda
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

6.  A case of severe hypertension caused by ACTH-independent macronodular adrenal hyperplasia.

Authors:  R Nocente; Marinis L De; A Mancini; A Bianchi; R Bellantone; L Lauriola; M Costanzo; Crea C De; G Gasbarrini; Silveri N Gentiloni
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

7.  High expression of adrenal P450 aromatase (CYP19A1) in association with ARMC5-primary bilateral macronodular adrenocortical hyperplasia.

Authors:  Annabel Berthon; Fady Hannah-Shmouni; Andrea Gutierrez Maria; Fabio R Faucz; Constantine A Stratakis
Journal:  J Steroid Biochem Mol Biol       Date:  2019-04-20       Impact factor: 4.292

8.  Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors.

Authors:  Hui-Pin Hsiao; Lawrence S Kirschner; Isabelle Bourdeau; Margaret F Keil; Sosipatros A Boikos; Somya Verma; Audrey J Robinson-White; Maria Nesterova; André Lacroix; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-06-09       Impact factor: 5.958

Review 9.  Arginine vasopressin (AVP): a review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system.

Authors:  Fabio Rotondo; Henriett Butz; Luis V Syro; George M Yousef; Antonio Di Ieva; Lina M Restrepo; Andres Quintanar-Stephano; Istvan Berczi; Kalman Kovacs
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

10.  Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma.

Authors:  Ulf Elbelt; Alessia Trovato; Michael Kloth; Enno Gentz; Reinhard Finke; Joachim Spranger; David Galas; Susanne Weber; Cristina Wolf; Katharina König; Wiebke Arlt; Reinhard Büttner; Patrick May; Bruno Allolio; Jochen G Schneider
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.